(Q36515393)

14 August 2017

1 reference

title

Sublingual immunotherapy in the treatment of adult allergic rhinitis patients (English)

1 reference

14 August 2017

1 reference

1 reference

Canonica GW

1

1 reference

14 August 2017

Passalacqua G

series ordinal

2

1 reference

14 August 2017

language of work or name

1 reference

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

61 Suppl 81

1 reference

14 August 2017

page(s)

20-23

1 reference

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Safety of sublingual-swallow immunotherapy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

The safety of sublingual-swallow immunotherapy: an analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Long-lasting clinical efficacy of allergen specific immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2006.01161.X

10.1111/J.1398-9995.2006.01161.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference